All In MedTech

FDA Clearance Tracker · P040043-S067

GORE TAG THORACIC ENDOPROSTHESIS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 21, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 21, 2014

Approved

Time to decision

95 days

Received Jul 18, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P040043-S067
Device name
GORE TAG THORACIC ENDOPROSTHESIS
Applicant location
Flagstaff, AZ
Received
Jul 18, 2014
Decided
Oct 21, 2014
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P040043

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN UPDATE TO THE LABELING FOR THE GORE TAG THORACICENDOPROSTHESIS TO REFLECT THE FINDINGS OF THE POST-APPROVAL STUDY.

Source documents

Other decisions for W. L. Gore & Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.